NasdaqGS:TEMLife Sciences
Is Tempus AI Still Attractive After Its 121.5% Surge and AI Healthcare Momentum in 2025?
If you have been wondering whether Tempus AI's rapid rise is justified or if the stock is already priced for perfection, you are not alone.
After a strong run, the stock is still up 121.5% year to date, including a 6.0% gain over the last month and 2.6% over the past week. This suggests that sentiment is anything but neutral.
Much of this excitement has been driven by Tempus AI's expanding role in applying AI to precision medicine and data driven clinical decision support, which investors...